Crossref journal-article
American Society of Clinical Oncology (ASCO)
Journal of Clinical Oncology (233)
Bibliography

Wiltschke, C., Wiedermann, U., Zurbriggen, R., Elandt, K., Brämswig, K., Jasinska, J., Pehamberger, H., Scheiner, O., & Zielinski, C. C. (2008). A phase I study to evaluate safety, immunogenicity and antitumor activity of a HER2 multi-peptide virosome vaccine in patients with metastatic breast cancer. Journal of Clinical Oncology, 26(15_suppl), 3055–3055.

Authors 9
  1. C. Wiltschke (first)
  2. U. Wiedermann (additional)
  3. R. Zurbriggen (additional)
  4. K. Elandt (additional)
  5. K. Brämswig (additional)
  6. J. Jasinska (additional)
  7. H. Pehamberger (additional)
  8. O. Scheiner (additional)
  9. C. C. Zielinski (additional)
References 0 Referenced 1

None

Dates
Type When
Created 8 years, 6 months ago (Feb. 24, 2017, 2:33 a.m.)
Deposited 5 years, 9 months ago (Nov. 27, 2019, 4:27 p.m.)
Indexed 3 years, 4 months ago (March 30, 2022, 12:42 p.m.)
Issued 17 years, 3 months ago (May 20, 2008)
Published 17 years, 3 months ago (May 20, 2008)
Published Print 17 years, 3 months ago (May 20, 2008)
Funders 0

None

@article{Wiltschke_2008, title={A phase I study to evaluate safety, immunogenicity and antitumor activity of a HER2 multi-peptide virosome vaccine in patients with metastatic breast cancer}, volume={26}, ISSN={1527-7755}, url={http://dx.doi.org/10.1200/jco.2008.26.15_suppl.3055}, DOI={10.1200/jco.2008.26.15_suppl.3055}, number={15_suppl}, journal={Journal of Clinical Oncology}, publisher={American Society of Clinical Oncology (ASCO)}, author={Wiltschke, C. and Wiedermann, U. and Zurbriggen, R. and Elandt, K. and Brämswig, K. and Jasinska, J. and Pehamberger, H. and Scheiner, O. and Zielinski, C. C.}, year={2008}, month=may, pages={3055–3055} }